HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christina Peters Selected Research

Osteopetrosis

4/2012Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christina Peters Research Topics

Disease

32Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2024 - 05/2003
17Neoplasms (Cancer)
02/2024 - 02/2007
14Leukemia
01/2022 - 01/2005
8Graft vs Host Disease (Graft-Versus-Host Disease)
05/2024 - 10/2005
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 12/2013
8Infections
01/2021 - 08/2003
7Residual Neoplasm
01/2021 - 01/2009
5Bronchiolitis Obliterans Syndrome
01/2018 - 10/2005
4Sickle Cell Anemia (Hemoglobin S Disease)
11/2023 - 04/2013
4Virus Diseases (Viral Diseases)
01/2021 - 10/2005
4Aplastic Anemia (Anemia, Hypoplastic)
05/2015 - 11/2013
3Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2016
2beta-Thalassemia (Cooley's Anemia)
03/2022 - 05/2014
2Mycoses (Diseases, Fungus)
01/2021 - 01/2017
2Communicable Diseases (Infectious Diseases)
06/2020 - 01/2020
2Hematologic Diseases (Blood Diseases)
01/2020 - 01/2020
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2020 - 04/2012
2Neutropenia
01/2017 - 03/2009
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2014 - 12/2013
2Juvenile Myelomonocytic Leukemia
09/2013 - 01/2005
2Disease Progression
08/2012 - 08/2011
1Ovarian Neoplasms (Ovarian Cancer)
04/2023
1Ovarian Epithelial Carcinoma
04/2023
1Necrosis
01/2022
1Fever (Fevers)
01/2021
1Pathologic Complete Response
01/2021
1Hemolysis
01/2021
1COVID-19
01/2021
1Viremia
01/2021
1Pure Red-Cell Aplasia
01/2021
1Vomiting
01/2020
1Hypersensitivity (Allergy)
01/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Mucositis
01/2020
1Iron Overload
01/2020
1Bacteremia
01/2019
1Osteonecrosis (Kienbock's Disease)
10/2018
1Cytokine Release Syndrome
01/2018
1Thalassemia
01/2018
1Febrile Neutropenia
01/2017
1Sepsis (Septicemia)
01/2017
1Lymphoma (Lymphomas)
01/2016
1Autosomal Recessive 3 Severe Congenital Neutropenia
10/2015
1idiopathic Aplastic anemia
10/2014
1Typical Teratoid Rhabdoid Tumor
02/2014
1Fanconi Anemia (Fanconi's Anemia)
12/2013
1Cytopenia
04/2013

Drug/Important Bio-Agent (IBA)

6Busulfan (Busulfex)FDA Link
11/2023 - 01/2016
5fludarabineIBA
11/2023 - 12/2013
5treosulfanIBA
11/2023 - 01/2016
3tisagenlecleucelIBA
12/2023 - 01/2018
3SteroidsIBA
09/2013 - 08/2011
2Chimeric Antigen ReceptorsIBA
02/2024 - 01/2018
2Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2019
2blinatumomabIBA
01/2021 - 01/2020
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2020 - 09/2013
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
10/2005 - 10/2005
1Thomsen-Friedenreich antibodiesIBA
05/2024
1GlobulinsIBA
05/2024
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2023
1PlatinumIBA
04/2023
1Glutathione (Reduced Glutathione)IBA
01/2022
1O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA
01/2022
1TransferasesIBA
01/2022
1ProcalcitoninIBA
01/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2021
1AntigensIBA
01/2021
1Hemagglutinins (Hemagglutinin)IBA
01/2021
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1tocilizumab (atlizumab)FDA Link
01/2018
1VancomycinFDA LinkGeneric
01/2017
1TeicoplaninIBA
01/2017
1Brentuximab VedotinIBA
06/2015
1Immunoconjugates (Immunoconjugate)IBA
06/2015
1Cytotoxins (Cytolysins)IBA
06/2015
1Ado-Trastuzumab EmtansineIBA
06/2015
1Blood Group Antigens (Blood Groups)IBA
05/2015
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2013
1Proteins (Proteins, Gene)FDA Link
10/2012

Therapy/Procedure

47Hematopoietic Stem Cell Transplantation
05/2024 - 01/2005
23Transplantation
01/2024 - 01/2005
21Stem Cell Transplantation
11/2023 - 05/2003
15Drug Therapy (Chemotherapy)
04/2023 - 05/2003
10Therapeutics
01/2020 - 01/2005
2Aftercare (After-Treatment)
08/2022 - 09/2014
2Cell Transplantation
01/2020 - 11/2019
2Homologous Transplantation
04/2015 - 06/2008
1Immunotherapy
02/2024
1Haploidentical Transplantation
01/2024
1Donor Selection
01/2021
1Consolidation Chemotherapy
01/2021
1Parenteral Nutrition
01/2020
1Antibiotic Prophylaxis
01/2017
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2015
1Radiotherapy
02/2014
1Isogeneic Transplantation
11/2013